Group One Trading’s Trinity Biotech TRIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-3,500
Closed -$12.7K 8203
2023
Q3
$12.7K Hold
3,500
﹤0.01% 6196
2023
Q2
$16.9K Hold
3,500
﹤0.01% 6093
2023
Q1
$16.4K Hold
3,500
﹤0.01% 5639
2022
Q4
$17.3K Buy
+3,500
New +$21.2K ﹤0.01% 5687
2022
Q1
Sell
-4,120
Closed -$29K 8731
2021
Q4
$29K Buy
4,120
+3,820
+1,273% +$36.1K ﹤0.01% 6753
2021
Q3
$3K Sell
300
-160
-35% -$1.88K ﹤0.01% 7893
2021
Q2
$7K Buy
460
+20
+5% +$333 ﹤0.01% 7670
2021
Q1
$8K Buy
+440
New +$10.6K ﹤0.01% 7133
2019
Q4
Sell
-4,800
Closed -$29K 5628
2019
Q3
$29K Buy
+4,800
New +$41.7K ﹤0.01% 4222
2017
Q2
Sell
-120
Closed -$4K 5093
2017
Q1
$4K Sell
120
-60
-33% -$1.88K ﹤0.01% 4342
2016
Q4
$6K Buy
+180
New +$6.2K ﹤0.01% 4075
2016
Q2
Sell
-2,000
Closed -$117K 4956
2016
Q1
$117K Buy
+2,000
New +$106K ﹤0.01% 2722
2015
Q3
Sell
-1,840
Closed -$166K 5201
2015
Q2
$166K Buy
+1,840
New +$159K ﹤0.01% 2672
2015
Q1
Sell
-400
Closed -$35K 5196
2014
Q4
$35K Sell
400
-2,260
-85% -$195K ﹤0.01% 3619
2014
Q3
$243K Sell
2,660
-1,820
-41% -$197K ﹤0.01% 2224
2014
Q2
$516K Buy
4,480
+3,080
+220% +$365K 0.01% 1625
2014
Q1
$170K Sell
1,400
-2,000
-59% -$262K ﹤0.01% 2580
2013
Q4
$427K Sell
3,400
-160
-4% -$19.2K 0.01% 1783
2013
Q3
$387K Sell
3,560
-440
-11% -$42.9K 0.01% 1833
2013
Q2
$337K Buy
+4,000
New +$332K 0.01% 1685

Other funds holding TRIB

Group One Trading's TRIB Position: Q4 2023 in Review

Group One Trading sold out of Trinity Biotech (TRIB) in Q4 2023, closing a stake of 3,338 shares — an estimated $12.2K sold.

Group One Trading first reported a position in TRIB in Q2 2013 and held it in 18 quarters. The position peaked at $1.15M in Q4 2013. 26 funds tracked by Wall St. Rank hold TRIB as of Q4 2023.

  • Group One Trading reported no remaining Trinity Biotech position as of Q4 2023 after selling out during the quarter.
  • Group One Trading sold 3,338 Trinity Biotech shares in Q4 2023, an estimated $12.2K.
  • Group One Trading first reported a position in Trinity Biotech in Q2 2013 and held it in 18 quarters.
  • Group One Trading's Trinity Biotech position peaked at $1.15M in Q4 2013.
  • 26 funds tracked by Wall St. Rank held Trinity Biotech as of Q4 2023.

Based on Group One Trading's 13F filing for Q4 2023, filed 14 Feb 2024.